Clinical trial
Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring
NCT05500391 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring
- Lead sponsor
- Centre Oscar Lambret
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 28, 2024
- Completion date
- July 31, 2032
- Enrollment
- 88 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma, clear cell, aggressive fibromatosis of abdominal wall (disorder), borderline ovarian tumor, carcinoma, small cell, carcinosarcoma, ovarian, gastrointestinal stromal tumors, glioma, mucinous adenocarcinoma of ovary, neuroendocrine tumors, ovarian germ cell tumor, serous tumor of ovary, sex cord-stromal tumor, stage i testicular nonseminomatous germ cell tumor, stage i testicular seminoma